远程医疗加速肝移植评估与等待名单登记
该回顾性研究纳入2005至2017年在里士满退伍军人医学中心接受肝移植评估的465例患者,其中232例通过远程医疗评估,233例为面对面评估。
要点
- 低MELD-Na评分患者从远程医疗中获益更大。
核心结论
- 远程医疗显著缩短从转诊至肝病医生首次评估及等待名单登记的时间,尤其对低MELD评分患者,且未改变移植时间或移植前死亡率。
研究设计与样本
- 回顾性研究,纳入2005至2017年里士满退伍军人医学中心465例接受肝移植评估的患者,其中232例远程医疗评估,233例面对面评估。
主要发现
- 意向治疗分析中,远程医疗组与面对面组移植前死亡率无显著差异。
临床怎么用
- 远程医疗可用于扩大肝移植评估的可及性,尤其适合低MELD评分患者,但需更多退伍军人系统外的研究确认其安全性和有效性。
局限性
- 研究为回顾性设计,且仅基于退伍军人事务医疗系统,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Liver transplantation is the only treatment that increases survival times of patients with decompensated cirrhosis. Patients who live farther away from a transplant center are disadvantaged. Health care delivery via telehealth is an effective way to manage patients with decompensated cirrhosis remotely. We investigated the effects of telehealth on the liver transplant evaluation process. METHODS: We performed a retrospective study of 465 patients who underwent evaluation for liver transplantation at the Richmond Veterans Affairs Medical Center from 2005 through 2017. Of these, 232 patients were evaluated via telehealth, and 233 via in-person evaluation. Using regression models, we evaluated the differential effects of telehealth vs usual care on placement on the liver transplant waitlist. We also investigated the effects of telehealth on time from referral to initial evaluation by a transplant hepatologist, liver transplantation, and mortality. RESULTS: Patients in the telehealth group were evaluated significantly faster than patients evaluated in person, without or with adjustment for potential confounders (21.7 vs 79.5 d; P < .01). Telehealth also was associated with a significantly shorter time on the liver transplant waitlist (138.8 vs 249 d; P < .01). After propensity-matched analysis, telehealth was associated with a reduction in the time from referral to evaluation (hazard ratio, 0.15; 95% CI, 0.09-0.21; P < .01) and listing (hazard ratio, 0.26; 95% CI, 0.12-0.40; P < .01), but not to transplantation. In the intent-to-treat analysis of all referred patients, we found no significant difference in pretransplant mortality between patients evaluated via telehealth vs in-person. There was statistically significant interaction between model for end-stage liver disease (MELD)-Na scores and time to evaluation (P = .009) and placement on the transplant waitlist (P = .002), with telehealth offering greater benefits to patients with low MELD-Na scores. CONCLUSIONS: Use of telehealth is associated with a substantial reduction in time from referral to initial evaluation by a hepatologist and placement on the liver transplant waitlist, especially for patients with low MELD scores, with no changes in time to transplantation or pretransplant mortality. More studies are needed, particularly outside of the Veterans Administration Health System, to confirm that telehealth is a safe and effective way to expand access for patients undergoing evaluation for liver transplantation.
引用
- John BV, Love E, Dahman B, et al. Use of Telehealth Expedites Evaluation and Listing of Patients Referred for Liver Transplantation. Clin Gastroenterol Hepatol. 2019. PMID: 31887445. doi:10.1016/j.cgh.2019.12.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。